MiniMed
Insulin pump systems
Free
Manage your diabetes therapy with the MiniMed™ app!
Manage your diabetes therapy with the MiniMed™ app! The MiniMed app connects to your MiniMed Flex™ pump system, letting you monitor glucose, adjust insulin delivery, and receive real-time alerts — all from your smartphone. View trends, track daily history, and get reminders for important actions. A new approach to making diabetes management simpler.
The app guides you through the startup process and provides an overview of data received from the MiniMed Flex™ pump and sensor. The MiniMed app is your primary source of information about your therapy and for controlling insulin delivery. Your data is automatically uploaded to CareLink™ software, simplifying the process of sharing information with your healthcare team and care partners. The MiniMed Flex system with SmartGuard™ feature automatically adjusts and corrects your sugar levels continuously throughout the day.
Refers to SmartGuard™ feature. Individual results may vary.
Important: The MiniMed™ app is only compatible with the MiniMed Flex™ system, it does not work with other MiniMed™ pumps. The MiniMed™ app should only be used with supported mobile devices and operating systems. To access the list of the supported mobile devices and operating systems, go to https://www.medtronicdiabetes.com/app-check
The MiniMed Flex™ system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex™ system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed Flex™ System consists of the following devices: MiniMed Flex™ Insulin Pump and the Simplera Sync™ sensor.
MiniMed Flex™ system is for type 1 ages 7 and over and type 2 ages 18 and over. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. For additional safety information and user guides, see https://bit.ly/MiniMedRisks.
WARNING: Do not use the MiniMed Flex™ system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex™ system. Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex™ system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://bit.ly/MiniMedRisks.
©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of the MiniMed company.
Ratings & Reviews
The developer, Minimed, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Contact Info
- Identifiers
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- MEDTRONIC MINIMED INC
- Size
- 230.3 MB
- Category
- Medical
- Compatibility
Requires iOS 17.0 or later.
- iPhone
Requires iOS 17.0 or later. - Apple Watch
Requires watchOS 10.0 or later.
- iPhone
- Languages
- English
- Age Rating
16+
- 16+
- Frequent
Medical Treatment information
- Medical Device
Yes
- Minimed indicated this app is a regulated medical device and complies with United States law.
- The information below has not been verified by Apple.
- FDA Owner/Operator Number
- 10094334
- Address
- 18000 Devonshire St
Northridge California 91325
United States - Phone Number
- +1 800-646-4633
- mobile@devices.minimed.com
- Use Statement
- MINIMED FLEX™ SYSTEM WITH SMARTGUARD™ TECHNOLOGY WITH SIMPLERA SYNC™ SENSOR
The MiniMed Flex™ system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex™ system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Simplera Sync™ sensor can be used one time and has a life up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly. However, some sensors may not survive the full wear period for a variety of reasons. Please be prepared to replace the sensor during the grace period to ensure sensor glucose values continue to be monitored.
The Simplera Sync™ sensor is not intended to be used directly to make therapy adjustments while the MiniMed Flex™ system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync™ sensor. The Simplera Sync™ sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Simplera Sync™ sensor in the abdomen or other body sites, including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
The Medtronic MiniMed Flex™ System consists of the following devices: MiniMed Flex™ Insulin Pump and the Simplera Sync™ sensor. The system requires a prescription from a healthcare professional. - Safety Information
- WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed Flex™ system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex™ system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex™ system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://bit.ly/MiniMedRisks
To report a problem or adverse event to the FDA, visit www.fda.gov/safety/report-problem-fda - Instructions for Use
- Visit the developer site
- Copyright
- © 2026 Medtronic MiniMed, Inc.